Business
Wayland Group Confirms “BfARM” award for German Cannabis production
Wayland Group Confirms “BfARM” award for German Cannabis production.
About this update from Wayland Group Corp
[{"type":"text","content":"\nTORONTO, May 21, 2019 (GLOBE NEWSWIRE) -- Wayland Group Corp. (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) today announced that its joint venture DEMECAN GmbH (“DEMECAN”), of which it holds 50% with an option to increase to 60% has been awarded three lots of domestic cannabis production in Germany by the Federal Institute for Drugs and Medical Devices (“BfArM”), after the withdrawal of a competitor’s complaint following an oral court hearing.   \n DEMECAN is awarded three lots of thirteen total, which makes DEMECAN one of three companies globally to achieve a cannabis license for domestic production in Germany, out of 79 applicants.DEMECAN will now begin production within Wayland’s Ebersbach facility, following completion of upgrades to quality and security systems.Additionally, Wayland GmbH has received its narcotics license from the Bundesopiumstelle, the narcotics division of BfArM.“We have worked hard to build our business to standards which exceed industry norms and are delighted to have been rewarded through this externally validated merit-based award to our joint venture partner DEMECAN in three lots of domestic cannabis production in Germany.  In the most highly competitive process for a federal license in the world, to date, we have demonstrated that our team and our joint venture partners can be successful in the most competitive significant new markets.  Additionally, receipt of our own narcotics license in Germany demonstrates further the high standards we live by as a company.  We are proud to be 1 of 3 in Germany for domestic production, one of four globally for end to end EU-GMP certificated export from Canada and import to the EU, and 1 of 6 globally for EU-GMP certified cannabis production.” Stated Ben Ward – CEO.About Wayland Group Wayland is a vertically integrated cultivator and processor of cannabis. The Company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a cannabis cultivation, extraction, formulation, and distribution business under federal licenses from the Government of Canada. The Company also has licenses in Colombia and production operations in Dresden, Saxony, Germany...